(Q37038888)

17 August 2017

1 reference

title

ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer (English)

1 reference

17 August 2017

1 reference

David P Turner

1

1 reference

17 August 2017

Dennis K Watson

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2008

1 reference

Expert Review of Anticancer Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

33-42

1 reference

17 August 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

ETS transcription factors and their emerging roles in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Defining ETS transcription regulatory networks and their contribution to breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Influence of small interfering RNA corresponding to ets homologous factor on senescence-associated modulation of prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

The epithelium-specific ETS protein EHF/ESE-3 is a context-dependent transcriptional repressor downstream of MAPK signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Tamoxifen: a most unlikely pioneering medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Peptide nucleic acids with a structurally biased backbone: effects of conformational constraints and stereochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Triplex-forming oligonucleotides - sequence-specific DNA ligands as tools for gene inhibition and for modulation of DNA-associated functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

siRNAs: applications in functional genomics and potential as therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Unlocking the potential of the human genome with RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Recent advances in the generation of human monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Selective inhibition of the human tie-1 promoter with triplex-forming oligonucleotides targeted to Ets binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

A wrench-shaped synthetic molecule that modulates a transcription factor-coactivator interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Small organic molecules that modulate gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Cancer gene therapy: fringe or cutting edge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Oncology. Recruiting the cell's own guardian for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.1.33

21 January 2018

Identifiers

DOI

10.1586/14737140.8.1.33

1 reference

17 August 2017

1 reference